Adjusted EBITDA up 35%, Operating Income up
87%
American Vanguard Corporation (NYSE: AVD) today announced
financial results for the first quarter ended March 31, 2024.
First Quarter 2024 Financial Highlights – versus First
Quarter 2023:
- Net sales of $135 million vs. $125 million
- Adjusted EBITDA1 of $15.5 million vs. $11.5 million
- Operating Income of $6.1 million vs. $3.3 million
- Net income of $1.6 million vs. $1.9 million
- Earnings per diluted share of $0.06 vs. $0.07
Eric Wintemute, Chairman and CEO of American Vanguard, stated:
“We attained improved operating leverage with a significant
increase in adjusted EBITDA and operating income, during the first
quarter as compared to last year. This is due in part to our cost
control initiatives, on account of which our operating expenses
reduced as a percent of net sales, even after including our
transformation costs. We expect to gain greater efficiencies
through our transformation program which we have begun in earnest
and which we expect will generate an additional $15 million of
adjusted EBITDA on an annualized basis by 2026.”
He continued, “Further, it is pleasing to note that we
experienced growth in all three businesses, US Crop, US Non-crop
and International. Within US Crop, we recorded strong sales of
granular soil insecticides (in light of a stable farm economy),
herbicides (in part due to seasonal demand and favorable weather
conditions) and cotton and peanut products (driven by increased
planted acres for those crops). The destocking initiatives from
last year have begun to subside to a degree; however, the
distribution channel is still exercising conservatism in their
procurement approach.”
Mr. Wintemute continued, “Within US Non-crop, we experienced
significantly higher sales, led by our mosquito adulticides (in
anticipation of tropical storm activity), pest strips (with a
resurgence in consumer and technical sales) and our OHP products
for nursery and ornamental uses. Our International business
recorded moderately higher sales, led by Mexico and APAC, despite
continued overstocking of generic products in other regions. All
in, we are encouraged by the resiliency of our markets during the
quarter.”
Mr. Wintemute concluded, “Market conditions remain stable with a
strong farm economy and a more relaxed procurement approach within
the distribution channel compared to last year. That said, in light
of concerns raised by USEPA, we have voluntarily suspended sales of
our herbicide Dacthal pending potential approval of a label that we
believe should answer the agency’s concerns. In light of these
factors, we are adjusting our annual targets to achieve an increase
in net sales of between 6% and 9% year over year and are setting
our adjusted EBITDA target to $60 - $70 million. We look forward to
giving you a more detailed presentation during our upcoming
earnings call.”
Conference Call
Eric Wintemute, Chairman & CEO, Bob Trogele, EVP & COO
and David T. Johnson, VP & CFO, will conduct a conference call
focusing on the financial results and strategic themes at 4:15 pm
ET on Thursday, May 9, 2024. Interested parties may participate in
the call by dialing 201-493-6744. Please call in 10 minutes before
the scheduled start time and ask for the American Vanguard call.
The conference call will also be webcast live via the News and
Media section of the Company’s web site at
www.american-vanguard.com. To listen to the live webcast, go to the
web site at least 15 minutes early to register, download and
install any necessary audio software. If you are unable to listen
live, the conference call will be archived on the Company’s web
site.
About American Vanguard
American Vanguard Corporation is a diversified specialty and
agricultural products company that develops and markets products
for crop protection and management, turf and ornamentals management
and public and animal health. Over the past 20 years, through
product and business acquisitions, the Company has expanded its
operations into 21 countries and now has over 1,000 product
registrations in 56 nations worldwide. Its strategy rests on three
growth initiatives – i) Core Business (through innovation of
conventional products), ii) Green Solutions (with over 120
biorational products – including fertilizers, microbials,
nutritionals and non-conventional products) and iii) Precision
Agriculture innovation (including SIMPAS prescriptive application
and Ultimus measure/record/verify technologies). American Vanguard
is included on the Russell 2000® and Russell 3000® Indexes. To
learn more about American Vanguard, please reference the Company’s
web site at www.american-vanguard.com.
The Company, from time to time, may discuss forward-looking
information. Except for the historical information contained in
this release, all forward-looking statements are estimates by the
Company’s management and are subject to various risks and
uncertainties that may cause results to differ from management’s
current expectations. Such factors include weather conditions,
changes in regulatory policy and other risks as detailed from
time-to-time in the Company’s SEC reports and filings. All
forward-looking statements, if any, in this release represent the
Company’s judgment as of the date of this release.
AMERICAN VANGUARD CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED BALANCE
SHEETS
(In thousands, except share
data)
(Unaudited)
ASSETS
March 31, 2024
December 31, 2023
Current assets:
Cash
$
13,709
$
11,416
Receivables:
Trade, net of allowance for credit losses
of $7,798 and $7,107, respectively
187,197
182,613
Other
7,395
8,356
Total receivables, net
194,592
190,969
Inventories
228,309
219,551
Prepaid expenses
7,446
6,261
Income taxes receivable
2,889
3,824
Total current assets
446,945
432,021
Property, plant and equipment, net
75,909
74,560
Operating lease right-of-use assets,
net
23,084
22,417
Intangible assets, net of amortization
168,723
172,508
Goodwill
50,469
51,199
Deferred income tax assets
3,307
2,849
Other assets
13,188
11,994
Total assets
$
781,625
$
767,548
LIABILITIES AND STOCKHOLDERS’
EQUITY
Current liabilities:
Accounts payable
$
64,642
$
68,833
Customer prepayments
28,520
65,560
Accrued program costs
74,343
68,076
Accrued expenses and other payables
15,927
16,354
Operating lease liabilities, current
6,358
6,081
Income taxes payable
5,633
5,591
Total current liabilities
195,423
230,495
Long-term debt, net
187,017
138,900
Operating lease liabilities, long term
17,407
17,113
Deferred income tax liabilities
7,157
7,892
Other liabilities
3,038
3,138
Total liabilities
410,042
397,538
Commitments and contingent liabilities
Stockholders' equity:
Preferred stock, $0.10 par value per
share; authorized 400,000 shares; none issued
—
—
Common stock, $0.10 par value per share;
authorized 40,000,000 shares; issued 34,754,634 shares at March 31,
2024 and 34,676,787 shares at December 31, 2023
3,475
3,467
Additional paid-in capital
113,223
110,810
Accumulated other comprehensive loss
(7,527
)
(5,963
)
Retained earnings
333,613
332,897
Less treasury stock at cost, 5,915,182
shares at March 31, 2024 and December 31, 2023
(71,201
)
(71,201
)
Total stockholders’ equity
371,583
370,010
Total liabilities and stockholders’
equity
$
781,625
$
767,548
AMERICAN VANGUARD CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED
STATEMENTS OF OPERATIONS
(In thousands, except per
share data)
(Unaudited)
For the three months ended
March 31
2024
2023
Net sales
$
135,143
$
124,885
Cost of sales
(92,725
)
(86,348
)
Gross profit
42,418
38,537
Operating expenses
Selling, general and administrative
(30,621
)
(26,402
)
Research, product development and
regulatory
(5,706
)
(8,870
)
Operating income
6,091
3,265
Change in fair value of an equity
investment
638
(22
)
Interest expense, net
(3,693
)
(1,686
)
Income before provision for income
taxes
3,036
1,557
Income tax (expense) benefit
(1,484
)
361
Net income
$
1,552
$
1,918
Earnings per common share—basic
$
0.06
$
0.07
Earnings per common share—assuming
dilution
$
0.06
$
0.07
Weighted average shares
outstanding—basic
27,844
28,367
Weighted average shares
outstanding—assuming dilution
28,128
29,073
AMERICAN VANGUARD CORPORATION
AND SUBSIDIARIES
ANALYSIS OF SALES
(Unaudited)
For the three months ended
March 31,
2024
2023
Change
% Change
Net sales:
U.S. crop
$
67,257
$
61,876
$
5,381
9
%
U.S. non-crop
17,768
13,899
3,869
28
%
Total U.S.
85,025
75,775
9,250
12
%
International
50,118
49,110
1,008
2
%
Total net sales
$
135,143
$
124,885
$
10,258
8
%
Total cost of sales
$
(92,725
)
$
(86,348
)
$
(6,377
)
7
%
Total gross profit
$
42,418
$
38,537
$
3,881
10
%
Total gross margin
31
%
31
%
AMERICAN VANGUARD CORPORATION
AND SUBSIDIARIES
CONDENSED CONSOLIDATED
STATEMENTS OF CASH FLOWS
(In thousands)
(Unaudited)
For the three months ended
March 31
2024
2023
Cash flows from operating activities:
Net income
$
1,552
$
1,918
Adjustments to reconcile net income to net
cash used in operating activities:
Depreciation and amortization of property,
plant and equipment and intangible assets
5,441
5,539
Amortization of other long-term assets
189
714
Provision for bad debts
700
581
Stock-based compensation
2,005
1,474
Change in deferred income taxes
(1,025
)
122
Change in liabilities for uncertain tax
positions or unrecognized tax benefits
35
371
Change in equity investment fair value
(638
)
22
Other
(5
)
72
Foreign currency transaction gains
(373
)
(446
)
Changes in assets and liabilities
associated with operations:
Increase in net receivables
(5,579
)
(8,779
)
Increase in inventories
(9,353
)
(33,731
)
Increase (decrease) in prepaid expenses
and other assets
(1,466
)
600
Change in income tax receivable/payable,
net
1,014
(2,965
)
(Decrease) increase in accounts
payable
(3,951
)
5,655
Decrease in customer prepayments
(37,037
)
(22,759
)
Increase in accrued program costs
6,399
10,660
Decrease in other payables and accrued
expenses
(332
)
(500
)
Net cash used in operating activities
(42,424
)
(41,452
)
Cash flows from investing activities:
Capital expenditures
(3,565
)
(2,590
)
Proceeds from disposal of property, plant
and equipment
23
—
Acquisition of a product line
—
(703
)
Intangible assets
(25
)
(15
)
Net cash used in investing activities
(3,567
)
(3,308
)
Cash flows from financing activities:
Payments under line of credit
agreement
(35,346
)
(27,300
)
Borrowings under line of credit
agreement
83,463
72,000
Net receipt from the issuance of common
stock under ESPP
430
480
Net (payment) receipt from the exercise of
stock options
—
18
Net payment from common stock purchased
for tax withholding
(14
)
(13
)
Repurchase of common stock
—
(557
)
Payment of cash dividends
(834
)
(851
)
Net cash provided by financing
activities
47,699
43,777
Net increase (decrease) in cash
1,708
(983
)
Effect of exchange rate changes on cash
and cash equivalents
585
223
Cash at beginning of period
11,416
20,328
Cash at end of period
$
13,709
$
19,568
AMERICAN VANGUARD CORPORATION
AND SUBSIDIARIES
RECONCILIATION OF NET INCOME
TO EBITDA
(In thousands)
(Unaudited)
Reconciliation of Net Income to EBITDA
March 31, 2024
March 31, 2023
Net income, as reported
$
1,552
$
1,918
Provision for income taxes
1,484
(361
)
Interest expense, net
3,693
1,686
Proxy costs
—
541
Depreciation and amortization
5,630
6,253
Stock compensation
2,005
1,474
Transformation costs
1,152
—
Adjusted EBITDA2
$
15,516
$
11,511
______________________________ 1 Adjusted earnings before
interest, taxes, depreciation, and amortization. Adjusted EBITDA is
not a financial measure calculated and presented in accordance with
U.S. generally accepted accounting principles (GAAP) and should not
be considered as an alternative to net income, operating income or
any other financial measure so calculated and presented, nor as an
alternative to cash flow from operating activities as a measure of
liquidity. The items excluded from adjusted EBITDA are detailed in
the reconciliation attached to this news release. Other companies
(including the Company’s competitors) may define adjusted EBITDA
differently. 2 Adjusted earnings before interest, taxes,
depreciation, and amortization. Adjusted EBITDA is not a financial
measure calculated and presented in accordance with U.S. generally
accepted accounting principles (GAAP) and should not be considered
as an alternative to net income, operating income or any other
financial measure so calculated and presented, nor as an
alternative to cash flow from operating activities as a measure of
liquidity. The items excluded from adjusted EBITDA are detailed in
the reconciliation attached to this news release. Other companies
(including the Company’s competitors) may define adjusted EBITDA
differently.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20240509081007/en/
Company Contact: American Vanguard Corporation Anthony Young,
Director of Investor Relations (949) 260-1200
anthonyy@amvac-chemical.com
Investor Representative: The Equity Group Inc.
www.theequitygroup.com Lena Cati Lcati@equityny.com
American Vanguard (NYSE:AVD)
Historical Stock Chart
From Apr 2024 to May 2024
American Vanguard (NYSE:AVD)
Historical Stock Chart
From May 2023 to May 2024